Clinical Trial Update: Impact of Oral Versus Intravenous 5-FU-Based Adjuvant Regimens on Sleep Quality and Depression in Patients With Gastrointestinal Cancers

View source ↗

Summary

A clinical trial evaluating oral (capecitabine) versus intravenous 5-fluorouracil–based adjuvant regimens for gastrointestinal cancers, assessing sleep quality …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Capecitabine (capecitabine)

Snippet

Sponsor: Ankara Etlik City Hospital | Conditions: Gastrointestinal Neoplasms | Status: RECRUITING